14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:ALXN
Delisted

Alexion Pharmaceuticals Stock Price (Quote)

$182.50
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $182.50 $182.50 Friday, 27th May 2022 ALXN stock ended at $182.50. During the day the stock fluctuated 0% from a day low at $182.50 to a day high of $182.50.
90 days $182.50 $182.50
52 weeks $174.72 $187.45

Historical Alexion Pharmaceuticals prices

Date Open High Low Close Volume
Aug 19, 2019 $113.06 $114.15 $111.70 $112.68 2 026 729
Aug 16, 2019 $110.27 $111.41 $109.57 $110.85 1 254 773
Aug 15, 2019 $107.84 $110.01 $107.61 $109.04 1 728 310
Aug 14, 2019 $110.04 $110.81 $107.61 $107.65 1 766 520
Aug 13, 2019 $108.95 $112.60 $108.47 $111.47 2 064 259
Aug 12, 2019 $109.07 $109.66 $107.39 $108.69 1 607 325
Aug 09, 2019 $111.16 $112.46 $108.87 $109.98 1 345 664
Aug 08, 2019 $109.52 $112.16 $108.91 $112.11 1 529 842
Aug 07, 2019 $107.92 $109.89 $106.89 $108.91 1 998 137
Aug 06, 2019 $108.95 $110.31 $107.51 $109.39 1 831 961
Aug 05, 2019 $110.45 $110.68 $106.79 $107.90 2 680 421
Aug 02, 2019 $113.96 $114.31 $110.76 $112.34 1 692 035
Aug 01, 2019 $113.50 $116.98 $113.50 $114.91 2 204 987
Jul 31, 2019 $114.81 $115.62 $111.70 $113.29 2 517 044
Jul 30, 2019 $111.69 $115.62 $110.84 $114.45 3 102 987
Jul 29, 2019 $114.65 $114.87 $109.83 $112.36 5 524 324
Jul 26, 2019 $118.97 $119.91 $113.90 $114.63 3 412 551
Jul 25, 2019 $120.48 $121.81 $117.82 $118.03 2 861 272
Jul 24, 2019 $125.00 $125.46 $116.21 $120.97 3 518 759
Jul 23, 2019 $122.42 $123.08 $121.52 $122.42 1 544 614
Jul 22, 2019 $121.49 $123.63 $121.25 $122.32 1 680 952
Jul 19, 2019 $124.12 $124.20 $120.77 $120.80 1 521 159
Jul 18, 2019 $123.01 $124.27 $121.77 $123.26 1 114 031
Jul 17, 2019 $122.79 $125.14 $122.49 $123.41 1 706 526
Jul 16, 2019 $123.59 $124.81 $122.65 $122.82 1 532 898
Click to get the best stock tips daily for free!

About Alexion Pharmaceuticals

Alexion Pharmaceuticals Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. The company offers Soliris (eculizumab), a monoclonal antibody for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a genetic blood disorder; and atypical hemolytic uremic syndrome (aHUS), a genetic disease. It provides Strensiq (asfotase alfa), a targeted enzyme replacement therapy for patients with hypophosp... ALXN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT